These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23221984)

  • 1. Association of hepatitis C with markers of hemostasis in HIV-infected and uninfected women in the women's interagency HIV study (WIHS).
    Kiefer EM; Shi Q; Hoover DR; Kaplan R; Tracy R; Augenbraun M; Liu C; Nowicki M; Tien PC; Cohen M; Golub ET; Anastos K
    J Acquir Immune Defic Syndr; 2013 Mar; 62(3):301-10. PubMed ID: 23221984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of markers of hemostasis with death in HIV-infected women.
    Kiefer E; Hoover DR; Shi Q; Kuniholm MH; Augenbraun M; Cohen MH; Golub ET; Kaplan RC; Liu C; Nowicki M; Tien PC; Tracy RP; Anastos K
    J Acquir Immune Defic Syndr; 2014 Nov; 67(3):287-94. PubMed ID: 25314249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study.
    Keating SM; Dodge JL; Norris PJ; Heitman J; Gange SJ; French AL; Glesby MJ; Edlin BR; Latham PS; Villacres MC; Greenblatt RM; Peters MG;
    PLoS One; 2017; 12(9):e0181004. PubMed ID: 28902848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS).
    Frederick T; Burian P; Terrault N; Cohen M; Augenbraun M; Young M; Seaberg E; Justman J; Levine AM; Mack WJ; Kovacs A
    AIDS Patient Care STDS; 2009 Nov; 23(11):915-23. PubMed ID: 19877800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current practices of screening for incident hepatitis C virus (HCV) infection among HIV-infected, HCV-uninfected individuals in primary care.
    Freiman JM; Huang W; White LF; Geng EH; Hurt CB; Taylor LE; Overton ET; Cachay ER; Kitahata MM; Moore RD; Rodriguez B; Mayer KH; Linas BP
    Clin Infect Dis; 2014 Dec; 59(12):1686-93. PubMed ID: 25186591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment.
    Kaplan RC; Landay AL; Hodis HN; Gange SJ; Norris PJ; Young M; Anastos K; Tien PC; Xue X; Lazar J; Parrinello CM; Benning L; Tracy RP
    J Acquir Immune Defic Syndr; 2012 Aug; 60(4):359-68. PubMed ID: 22592585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: the fat redistribution and metabolic change in HIV infection (FRAM) study.
    Reingold J; Wanke C; Kotler D; Lewis C; Tracy R; Heymsfield S; Tien P; Bacchetti P; Scherzer R; Grunfeld C; Shlipak M
    J Acquir Immune Defic Syndr; 2008 Jun; 48(2):142-8. PubMed ID: 18344877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contributions of HIV, hepatitis C virus, and traditional vascular risk factors to peripheral artery disease in women.
    Cedarbaum E; Ma Y; Scherzer R; Price JC; Adimora AA; Bamman M; Cohen M; Fischl MA; Matsushita K; Ofotokun I; Plankey M; Seaberg EC; Yin MT; Grunfeld C; Vartanian S; Sharma A; Tien PC
    AIDS; 2019 Nov; 33(13):2025-2033. PubMed ID: 31335806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with hepatitis C viremia in a large cohort of HIV-infected and -uninfected women.
    Operskalski EA; Mack WJ; Strickler HD; French AL; Augenbraun M; Tien PC; Villacres MC; Spencer LY; Degiacomo M; Kovacs A
    J Clin Virol; 2008 Apr; 41(4):255-63. PubMed ID: 18243785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study.
    Armah KA; Quinn EK; Cheng DM; Tracy RP; Baker JV; Samet JH; Freiberg MS
    BMC Infect Dis; 2013 Aug; 13():399. PubMed ID: 23987993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection.
    Lamoury FM; Hajarizadeh B; Keoshkerian E; Feld JJ; Amin J; Teutsch S; Matthews GV; Hellard M; Dore GJ; Lloyd AR; Applegate TL; Grebely J;
    BMC Infect Dis; 2016 Jun; 16():241. PubMed ID: 27246604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women.
    Kerzerho J; McIlvaine EJ; Anthony P; Mack WJ; Wang CH; Frederick T; Operskalski E; Chen Z; Al-Harthi L; Landay A; Young MA; Tien PC; Augenbraun M; Strickler HD; Akbari O; Golub ET; Sharp GB; Kovacs A
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):172-80. PubMed ID: 26761519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial/ethnic differences in spontaneous HCV clearance in HIV infected and uninfected women.
    Sarkar M; Bacchetti P; Tien P; Mileti E; French AL; Edlin BR; Keller M; Seaberg E; Nowicki MJ; Young M; Peters MG
    Dig Dis Sci; 2013 May; 58(5):1341-8. PubMed ID: 23179159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of opiate use and hepatitis C virus infection on risk of diabetes mellitus in the Women's Interagency HIV Study.
    Howard AA; Hoover DR; Anastos K; Wu X; Shi Q; Strickler HD; Cole SR; Cohen MH; Kovacs A; Augenbraun M; Latham PS; Tien PC
    J Acquir Immune Defic Syndr; 2010 Jun; 54(2):152-9. PubMed ID: 20190642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-Related Quality of Life in HIV-Infected and At-Risk Women: The Impact of Illicit Drug Use and Hepatitis C on a Community Preference Weighted Measure.
    Aden B; Nosyk B; Wittenberg E; Schackman BR
    Med Decis Making; 2014 Aug; 34(6):800-8. PubMed ID: 24106234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.
    Swanson S; Ma Y; Scherzer R; Huhn G; French AL; Plankey MW; Grunfeld C; Rosenberg WM; Peters MG; Tien PC
    J Infect Dis; 2016 Apr; 213(7):1079-86. PubMed ID: 26621911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostasis biomarkers and incident cognitive impairment: the REGARDS study.
    Gillett SR; McClure LA; Callas PW; Thacker EL; Unverzagt FW; Wadley VG; Letter AJ; Cushman M
    J Thromb Haemost; 2018 Jul; 16(7):1259-1267. PubMed ID: 29733497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
    Kahn SR; Solymoss S; Flegel KM
    CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hepatitis C and HIV on cognition in women: data from the Women's Interagency HIV Study.
    Crystal H; Kleyman I; Anastos K; Lazar J; Cohen M; Liu C; Pearce L; Golub E; Valcour V; Ho A; Strickler H; Peters M; Kovacs A; Holman S; Kreek MJ; Manly J
    J Acquir Immune Defic Syndr; 2012 Feb; 59(2):149-54. PubMed ID: 22107817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels.
    Shah S; Ma Y; Scherzer R; Huhn G; French AL; Plankey M; Peters MG; Grunfeld C; Tien PC
    AIDS; 2015 Jul; 29(11):1325-33. PubMed ID: 25870985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.